ADC Therapeutics (ADCT) Prepaid Assets (2019 - 2026)
ADC Therapeutics (ADCT) posted Prepaid Assets of $5.7 million for Q1 2026, down 6.74% sequentially from $6.1 million in Q4 2025, and down 20.97% YoY from $7.2 million in Q1 2025.
ADC Therapeutics (ADCT) Prepaid Assets (2019 - 2026) Analysis & Trends
ADC Therapeutics has reported Prepaid Assets for 8 years, with the latest figure at $5.7 million in Q1 2026.
- Quarterly Prepaid Assets fell 20.97% year-over-year to $5.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.7 million (down 20.97% YoY) and the FY2025 annual result came in at $6.1 million, down 35.62% from the prior year.
- Prepaid Assets declined to $5.7 million in Q1 2026 per ADCT's latest filing, from $6.1 million in the prior quarter.
- Over five years, Prepaid Assets peaked at $27.2 million in Q1 2023 and troughed at $5.7 million in Q2 2025.
- A 5-year average of $14.4 million and a median of $16.7 million in 2024 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2023 and 2025: Prepaid Assets jumped 81.09% in 2023, then plunged 68.18% in 2025.
- Over 5 years, Prepaid Assets stood at $23.5 million in 2022, then slumped by 55.97% to $10.3 million in 2023, then declined by 8.64% to $9.4 million in 2024, then slumped by 35.62% to $6.1 million in 2025, then declined by 6.74% to $5.7 million in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $5.7 million, $6.1 million, and $5.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | ADC Therapeutics | 154.55 Mn | -64.56 Mn | 17.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.38 Mn |
| Mar 31, 2026 | 5.67 Mn |
| Dec 31, 2025 | 6.08 Mn |
| Sep 30, 2025 | 5.93 Mn |
| Jun 30, 2025 | 5.66 Mn |
| Mar 31, 2025 | 7.18 Mn |
| Dec 31, 2024 | 9.45 Mn |
| Sep 30, 2024 | 18.63 Mn |
| Jun 30, 2024 | 17.18 Mn |
| Mar 31, 2024 | 16.74 Mn |
| Dec 31, 2023 | 10.34 Mn |
| Sep 30, 2023 | 21.28 Mn |
| Jun 30, 2023 | 22.00 Mn |
| Mar 31, 2023 | 27.17 Mn |
| Dec 31, 2022 | 23.50 Mn |
| Sep 30, 2022 | 18.24 Mn |
| Jun 30, 2022 | 12.15 Mn |
| Mar 31, 2022 | 18.25 Mn |
| Dec 31, 2021 | 17.30 Mn |
| Sep 30, 2021 | 14.31 Mn |